Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. junior Avg
|
|
New words:
Abgenix, affirmed, Affymax, Albuquerque, alfa, alpha, Amunix, Andrew, anti, Antigen, antiplatelet, aptamer, Armstrong, Attenua, Atugen, Augustine, Ave, Aviragen, Barry, Bayer, bench, Bering, Berkeley, bioanalytical, BioSurface, Bioverativ, bispecific, CA, Cambridge, Camitro, capitalist, Carnegie, Cavanaugh, Ception, CFO, CFP, Christoffersen, Christopher, clause, CMC, CMO, College, combinatorial, constructive, constructively, Currie, CytomX, Damon, Danforth, DemandTM, depletion, diagram, disagreement, dismissal, dissertation, DMA, doctoral, Dtd, Dynavax, Eastman, entrepreneur, Essex, explore, Faraday, Fellow, Flex, Fogarty, forward, founder, fractional, Gary, Genome, GPCo, graduated, Guido, Hansoo, Harvard, HCPVIII, HCPVIIILLC, HCVVIII, Heinz, hematology, hemoglobin, Hetherington, highest, Horizon, Howard, IBM, ideally, illustrated, Immanuel, immaterial, insignificant, Inspiration, inter, intravenously, Iomai, Jersey, JJDC, Johannesburg, JonesTrading, Keyoung, kickback, KPMG, Lawlor, Leap, lessee, LeukoSite, Levy, limb, Littlechild, Littlefield, LP, Lutsi, Macugen, Marty, marzeptacog, Master, McGill, Mellon, Menlo, Mereo, Mexico, Micro, Mirabelli, mission, MMP, month, Morgenthaler, mortality, Mosaic, mouse, MP, multicenter, Nancy, native, Neuropore, NICE, NIH, nonreciprocal, notification, Noxxon, NSERC, OfferingTM, OMT, OPKO, oral, Osprey, overseen, Park, Pathwork, pattern, Pavey, PDL, pecuniary, pegylated, penalty, Pennsylvania, Petri, plasma, Plexxikon, Postdoctoral, prasugrel, preemption, Principia, prone, Protagonist, Ralph, regain, regained, ReoPro, Replidyne, rescheduled, retroactively, Ribozyme, Rinat, RNA, Robert, Robery, Ron, Rosetta, ROU, RXi, Sangart, School, scientist, securitization, Shire, sickle, Silence, Sirna, sit, Sofinnova, SQ, Steve, subcutaneously, Sun, surmounted, Susan, Sutter, Symphogen, territory, Thangaraj, thousand, tranche, transient, trauma, trough, UK, untested, Vainio, weak, Werner, wife, Winchell, Witwatersrand, Yale, Zenapax
Removed:
acquirer, adjusting, allocation, attention, certification, composite, confirming, deferral, exhibit, feasibility, harmful, Index, intangible, irrespective, landlord, language, lawfully, library, loan, long, marketable, modulating, NDA, negotiating, nonqualified, pharmacoeconomic, prominent, rapid, recoverable, reinvestment, secondary, separately, shorter, speed, substituted, Supplementary, utilized
Filing tables
Filing exhibits
Related press release
GYRE similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements of Catalyst Biosciences, Inc. on Form S-8 (Nos. 333-133882, 333-189143, 333-133881, 333-160331, 333-185888, 333-206523, 333-206526, and 333-212345) and Form S-3 (No. 333-210248) of our report dated March 6, 2017, on our audits of the consolidated financial statements as of December 31, 2016 and 2015, and for the years then ended, which report is included in this Annual Report on Form 10-K to be filed on or about March 8, 2017.
/s/ EISNERAMPER LLP
Iselin, New Jersey
March 8, 2017